Diagnosis of Hypertension
Hypertension is diagnosed when blood pressure measurements average ≥140/90 mmHg on multiple occasions, confirmed through out-of-office monitoring (ambulatory or home blood pressure monitoring) before initiating treatment, particularly for readings between 140-159/90-99 mmHg. 1, 2
Diagnostic Criteria and Measurement Technique
Blood Pressure Measurement Standards
- Use a properly maintained, calibrated, and validated device with appropriate cuff size for arm circumference 1
- Measure seated blood pressure with arm supported at heart level, patient relaxed, avoiding talking during measurement 1
- Record the mean of at least 2 readings per visit; more recordings needed if marked differences exist 1
- Never treat based on an isolated reading 1
- Standing blood pressure should be measured in elderly or diabetic patients to exclude orthostatic hypotension 1
Confirmation Strategy
- For blood pressure 140-159/90-99 mmHg: Confirm diagnosis using ambulatory blood pressure monitoring (ABPM) or home blood pressure monitoring (HBPM) before starting treatment 2
- ABPM defines hypertension as daytime average ≥135/85 mmHg 1
- Diagnosis requires measurements on at least 2-3 separate visits with 2 measurements per visit 2
- Blood pressure should be measured at least every 5 years until age 80 in normotensive individuals 1
- Annual monitoring for those with "high-normal" values (130-139/85-89 mmHg) 1
Initial Evaluation
- Calculate 10-year cardiovascular risk using ASCVD calculator (US) or SCORE (Europe) 2
- Routine laboratory investigations: urinalysis for protein and blood, serum creatinine and electrolytes, fasting blood glucose, lipid profile (total and HDL cholesterol), and electrocardiogram 1, 2
- Assess for secondary causes, target organ damage, and cardiovascular risk factors 1
Initial Treatment of Hypertension
For stage 1 hypertension (140-159/90-99 mmHg) with 10-year cardiovascular risk <10% and no target organ damage or diabetes, initiate lifestyle modifications alone; for higher risk patients or stage 2 hypertension (≥160/100 mmHg), start both lifestyle modifications and pharmacological therapy simultaneously. 2
Treatment Decision Algorithm
Stage 1 Hypertension (140-159/90-99 mmHg)
- Low risk (10-year CVD risk <10%, no target organ damage, no diabetes): Lifestyle modifications alone 2
- High risk (10-year CVD risk ≥10% OR target organ damage OR diabetes): Lifestyle modifications PLUS pharmacological therapy 2
Stage 2 Hypertension (≥160/100 mmHg)
- Immediate combination of lifestyle modifications and pharmacological therapy 2
Non-Pharmacological Interventions
All hypertensive patients require lifestyle modifications regardless of medication status: 2, 3
- Sodium restriction to <1500 mg/day 2
- Increased potassium intake (3500-5000 mg/day) 2
- Weight loss if overweight or obese 2, 3
- Regular physical activity: 90-150 minutes per week 2
- Alcohol moderation: ≤2 drinks/day for men, ≤1 drink/day for women 2
- Healthy dietary pattern (DASH diet approach) 3
Pharmacological Treatment
First-Line Agents
The following four drug classes are recommended as first-line therapy: 2, 3
- Thiazide or thiazide-like diuretics (e.g., hydrochlorothiazide 12.5-25 mg, chlorthalidone) 2, 3
- ACE inhibitors (e.g., lisinopril 10 mg initial dose) 2, 4
- Angiotensin receptor blockers (ARBs) 2, 3
- Calcium channel blockers (e.g., amlodipine) 2, 3
Specific Dosing for Lisinopril
- Initial dose: 10 mg once daily in adults 4
- Usual dosage range: 20-40 mg per day as single daily dose 4
- If taking diuretics: Start with 5 mg once daily 4
- Doses up to 80 mg have been used but provide no greater effect 4
Special Population Considerations
- Diabetes or chronic kidney disease: Prefer ACE inhibitors or ARBs as initial agents 2
- Black patients: Initiate with calcium channel blocker or thiazide diuretic 1
- History of myocardial infarction, heart failure, or angina: β-blockers indicated 1
Critical Contraindication
- Never combine ACE inhibitors with ARBs 2
Blood Pressure Targets
Target blood pressure varies by patient characteristics: 2, 3
- Adults <65 years: <130/80 mmHg 3
- Adults ≥65 years: SBP <130 mmHg 3
- Patients with diabetes, chronic kidney disease, or established CVD: <130/80 mmHg 2
- Minimum acceptable control (audit standard): <150/90 mmHg 1
Monitoring and Follow-Up
Laboratory Monitoring
- Monitor electrolytes and renal function 2-4 weeks after initiating ACE inhibitors, ARBs, or diuretics, then regularly thereafter 2
Blood Pressure Monitoring
- Regular blood pressure monitoring with treatment adjustment as needed to achieve target 2
- Consider ABPM for unusual variability, suspected white coat hypertension, resistant hypertension, or nocturnal hypertension 1
Common Pitfalls to Avoid
- Do not use immediate-release nifedipine for hypertensive urgencies 5
- Avoid β-blockers as first-line therapy in general population without specific indications 1
- The appearance of hypotension after initial dosing does not preclude careful subsequent titration 4
- If adding a diuretic to lisinopril, the lisinopril dose may need reduction 4